NCT06157684

Brief Summary

This is a randomized controlled trial to assess the effect of routine exercise counseling compared to the recommendation for postprandial ambulation on infant birthweight among pregnant people with gestational diabetes mellitus. The primary outcome is birthweight percentile for gestational age at delivery. Secondary outcomes include feasibility and acceptability, need for metformin or insulin for glycemic control, mode of delivery, neonatal hypoglycemia. Participants will be counseled to either complete 20 minutes of walking after meals, or be counseled with routine exercise counseling of 30 minutes of low-impact 5x a week. Their activity will be tracked by "FitBit" pedometers and uploaded via bluetooth to a database for review. They will continue to receive routine obstetric and diabetes care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 20, 2023

Completed
8 months until next milestone

First Posted

Study publicly available on registry

December 6, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

December 6, 2023

Status Verified

December 1, 2023

Enrollment Period

2.1 years

First QC Date

April 20, 2023

Last Update Submit

December 1, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Infant birthweight percentile

    Birthweight percentile for gestational age for neonatal sex

    Single time point - at birth

Secondary Outcomes (5)

  • infant birthweight

    Single time point - at birth

  • neonatal hypoglycemia treatment

    within 48 hours of birth

  • mode of delivery

    Single time point

  • fetal macrosomia

    Single time point - at birth

  • need for insulin or metformin during pregnancy

    from diagnosis to delivery of infant

Other Outcomes (1)

  • feasibility and acceptability

    3 months after the study conclusion

Study Arms (2)

Postprandial Ambulation

EXPERIMENTAL

Participants are counseled to walk for 20 minutes within 2 hours following meals daily.

Behavioral: Postprandial ambulation

Routine exercise counseling

NO INTERVENTION

Participants are counseled on routine ADA recommendations for 30 minutes of low-impact exercise 5 times a week

Interventions

See arm description

Postprandial Ambulation

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients who are diagnosed with gestational diabetes and receive care at the Maternal Fetal Medicine Diabetes in Pregnancy Program and who are fluent in English or Spanish.

You may not qualify if:

  • Pre-existing type 1 or type 2 diabetes, and those diagnosed with gestational diabetes in the first trimester. Patients who are either physically unable to ambulate or who have other contraindications to ambulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Women & Infants Hospital of Rhode Island

Providence, Rhode Island, 02905, United States

RECRUITING

MeSH Terms

Conditions

Diabetes, GestationalPregnancy ComplicationsPregnancy in DiabeticsFetal Macrosomia

Condition Hierarchy (Ancestors)

Female Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesFetal DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDiabetes ComplicationsBirth WeightBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical and Research Fellow, Principal Investigator

Study Record Dates

First Submitted

April 20, 2023

First Posted

December 6, 2023

Study Start

October 1, 2022

Primary Completion

October 31, 2024

Study Completion

December 31, 2024

Last Updated

December 6, 2023

Record last verified: 2023-12

Locations